Displaying 241 - 250 of 535

2019 Consensus Statement on the Evaluation of Incidentally Discovered Adrenal Masses

This consensus statement provides a practical approach to the evaluation of incidentally discovered adrenal masses, presenting five patient case scenarios selected to highlight a unique and relatively characteristic presentation that clinicians may encounter and answering key questions to help guide evaluation, diagnosis, management, and treatment. Read Consensus Statement more

2015 Consensus Statement for Pre-Operative Therapy in Management of Patients with Acromegaly

This statement addresses the use of somatostatin-receptor ligands (SRLs) as preoperative therapy for individuals with acromegaly to improve outcomes. Read Consensus Statement more

2022 Consensus Statement on Minimally Invasive Procedures for Benign and Malignant Thyroid Lesions

This consensus statement provides information on novel minimally invasive therapeutic interventions for thyroid malignancies such as percutaneous ethanol injection and thermal ablation. The statement summarizes existing knowledge and provides guidance on indications, techniques, complications, and follow-ups for care of patients with benign and malignant thyroid lesions. Read Consensus Statement more

2021 Consensus Statement on Pediatric Benign and Malignant Thyroid Surgery

Co-sponsored by the American Head and Neck Society Endocrine Surgery Section (AHNS) This consensus statement outlines expert opinion and practical information on the evaluation of thyroid nodules, surgical considerations, and postoperative monitoring for children and adolescents with benign and malignant thyroid lesions. Read Consensus Statement more

2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

Co-sponsored by the American Association for the Study of Liver Diseases (AASLD) This guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders. Read Guideline   AACE Podcasts Episode 31: Listen to endocrine expert Vin Tangpricha, M.D., Ph.D., as he interviews AACE Co-… more

2017 Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists

TThis 2017 update in CPG development focused on updated ratings for evidence and grading of recommendations for a more transparent process. Coming soon--2023 update to the AACE Protocol for Guidance Document Development. Read Protocol more

Guidance Documents in Development

Clinical Practice Guideline (developed according to GRADE framework) Dyslipidemia Published February 2025 Consensus Statement Multiple Endocrine Neoplasia Type 1 Published April 2025 Algorithm Obesity In process Algorithm Dyslipidemia In process Algorithm Type 2 Diabetes In process Guideline Postmenopausal Osteoporosis In process Consensus Statement Diabetes Technology In process more

Topic Nomination Form for AACE Clinical Guidance Document

Only topics nominated by AACE members in good standing will be considered. Topics are reviewed by the Clinical Practice Guidelines (CPG) Oversight Committee twice a year (approximately in March and September). Approval does not guarantee that a guidance document on the topic will be developed within a certain timeframe. AACE plans initiation of approved topics in the context of current and other approved documents in queue for development, dependent on budget and availability of personnel and resources. AACE members who nominated approved topics may apply to be considered for selection… more

Archived Guidance Documents

2020 Comprehensive Type 2 Diabetes Mellitus Algorithm 2019 Comprehensive Type 2 Diabetes Mellitus Algorithm 2018 Comprehensive Type 2 Diabetes Mellitus Algorithm 2018 Position Statement on Dysglycemia-Based Chronic Disease 2018 Position Statement on Integration of Insulin Pumps and Continuous Glucose Monitoring in Patients with Diabetes Mellitus 2017 Clinical Practice Guideline for the Management of Dyslipidemia and Prevention of Cardiovascular Disease 2017 Comprehensive Type 2 Diabetes Mellitus Algorithm 2017 Position Statement on Menopause 2017… more

Qualifications to Serve on a Guidance Document Task Force

Chair and Author Qualifications to Serve on a Guidance Document Task Force To be considered to serve as a Chair/Co-Chair/Vice Chair or an author of an AACE guideline or consensus statement for a particular task force, AACE members must complete an application and a disclosure form, submit their curriculum vitae, and meet the following qualifications: Required qualifications
  • Current AACE member in good standing
  • Active in practice within last 5 years
  • Publications:
    • Chairs: Two (first or senior author) publications on the…
more